Massive Prazosin Recall Issued Over Cancer Risk, Says FDA

If you take prazosin for high blood pressure or PTSD, it’s time to double-check your prescription. The FDA confirmed that more than 580,000 bottles of the drug have been pulled from shelves nationwide after testing revealed the potential presence of a chemical linked to cancer.

The medication, prazosin hydrochloride, is commonly used to help blood vessels relax and also treat nightmares in those with PTSD. It’s sold in 1 mg, 2 mg, and 5 mg capsules.

New Jersey-based Teva Pharmaceuticals USA and drug distributor Amerisource Health Services initiated the voluntary recall earlier this month. The FDA classified the move as a Class II recall, meaning the product could pose a temporary or medically reversible health problem.

According to the agency, “some of the medication may have nitrosamine impurities that are considered potentially carcinogenic.” These impurities can develop during manufacturing or while a drug is stored.

Teva Pharmaceuticals has yet to issue a public statement in response to the recall.

Patients currently taking prazosin are advised to consult their doctors or pharmacists to confirm if their batch is affected.